Biomarker ID | 1439 |
PMID | 24893170 |
Year | 2014 |
Biomarker | miR_19a + miR_19b + miR_345 + miR_519c_5p |
Biomarker Basis | Expression Based |
Biomolecule | miRNA |
Source | Tissue |
Subjects | Humans |
Regulation | NA |
Odds Ratio/Hazard Ratio/Relative Risk | OR: [miR_19a: 0.89 (95% CI: 0.01, 55.72)]; [miR_19b: 17.38 (95% CI: 0.21-1431.62 )]; [miR_345: 0.002 (95% CI: 0.00-0.42)]; [miR_519c_5p: 0.16 (95% CI: 0.01-3.14)]; |
Effect on Pathways | NA |
Experiment | Gleason Score ≥7 or Gleason Score =6 |
Type of Biomarker | Prognostic |
Cohort | A validation cohort consisted of 25 cases and 35 controls. Gleason score of 7 or higher (case group) and a pathologic Gleason score of 6 (control group). |
Senstivity | NA |
Specificity | NA |
AUC | 0.940 (95% CI: 0.87-1.00) |
Accuracy | NA |
Level Of Significance | p<0.05 |
Method Used | qRT-PCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |